Dr Fiona Swain is a clinical haematologist practising at the Princess Alexandra Hospital in Brisbane and is lead of the CAR-T Cell Program. She is also completing a PhD in relapsed/refractory DLBCL in A/Prof Colm Keane's laboratory.

Dr Joshua Tobin is a Staff Specialist Haematologist at Princess Alexandra Hospital and Co-Group Leader of the Blood Cancer Research Group at Mater Research Institute–UQ. His clinical and research focus is lymphoma, with a translational program centered on personalised immunotherapy development and biomarker-directed clinical trials.

Dr Zachary Hawula is a postdoctoral research fellow in the Lymphoma Research Lab at the Frazer Institute. Having completed his PhD at QUT in 2021. Since begining his role in the Lymphoma Research Lab in 2022, Zachary is now focused on Primary Central Nervous System Lymphoma and Secondary CNS Lymphoma.

Dr Cale Burge completed his Haematology training in Sydney Local Health District and South Western Sydney Local Health District in NSW and is currently the Cellular Therapies Fellow at Royal Prince Alfred Hospital.

Melinda Burgess is a postdoctoral researcher at the Frazer Institute UQ and Princess Alexandra Hospital. She completed her PhD at Griffith University in 2024, investigating macrophage-mediated immune responses in CLL. Her current research focuses on the tumour immune microenvironment of B-cell lymphomas using integrated genomic, transcriptomic, single-cell, and spatial approaches.

Sean is an early career haematologist at the Royal Brisbane & Women's hospital with a clinical and research interest in lymphoma, CLL and CAR-T. He has a special interest in translational and clinical aspects of ICAHT post CAR-T.

Rory is a NZ and Aus-trained haematologist at North Shore and Waitakere hospitals in Auckland. He has special interest in clinical trials and research in lymphoid malignancies